.Duration of therapy with azacitidine in MDS
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update / Silverman LR, Fenaux P, Mufti GJ, Santini V, Hellström-Lindberg E, Gattermann N, Sanz G, List AF, Gore SD, Seymour JF, Backstrom J, McKenzie D, Beach CL.. - In: ECANCERMEDICALSCIENCE. - ISSN 1754-6605. - STAMPA. - 2:(2008), pp. 118-118. [10.3332/ecancer.2008.118]
The effects of continued azacitidine treatment cycles on response in higher risk patients with myelodysplastic syndromes: an update.
SANTINI, VALERIA;
2008
Abstract
.Duration of therapy with azacitidine in MDS
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
manuscript.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
125 kB
Formato
Adobe PDF
|
125 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
